title: Transforming growth factor-beta1 modulates angiotensin II-induced calcium release in vascular smooth muscle cells from spontaneously hypertensive rats.
abstract: OBJECTIVE
  To investigate the role of transforming growth factor-beta1 (TGF-beta1) on Ca2+-dependent mechanisms elicited by angiotensin II in aortic vascular smooth muscle cells (VSMC) of Wistar- Kyoto (WKY) rats and spontaneously hypertensive rats (SHR).
  
  
  METHODS
  Cai2+ release induced by angiotensin II (1 micromol/ l) was studied in cultured VSMC isolated from the aortas of 6-week-old WKY rats and SHR. Intracellular Ca2+ (Cai2+) was assessed in Fura-2 loaded cells using fluorescent imaging microscopy. Angiotensin II receptors were analysed by binding studies.
  
  
  RESULTS
  Pretreatment of VSMC for 24 h with TGF-beta1 significantly increased angiotensin II-induced Cai2+ mobilization from internal stores in SHR, while Ca2+ influx was not altered. This effect involves tyrosine kinase and is not due to an increase in angiotensin II binding sites, or a change in the affinity of the receptors. By contrast, TGF-beta1 did not modify the response of VSMC from WKY rats to angiotensin II.
  
  
  CONCLUSIONS
  These results help our understanding of the interactions between the pathways activated by TGF-beta1 and the G protein-coupled receptor signalling pathway, and their role in genetic hypertension.
authors.affiliation: INSERM U337, Facultè Broussais-Hotel Dieu, Paris, France.
authors.forename: H
authors.initials: H
authors.lastname: Bouillier
authors.forename: E
authors.initials: E
authors.lastname: Samain
authors.forename: S
authors.initials: S
authors.lastname: Miserey
authors.forename: C
authors.initials: C
authors.lastname: Perret
authors.forename: J F
authors.initials: JF
authors.lastname: Renaud
authors.forename: M
authors.initials: M
authors.lastname: Safar
authors.forename: G
authors.initials: G
authors.lastname: Dagher
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D001692:Biological Transport / Q000187:drug effects; D002118:Calcium / Q000378:metabolism*; D002478:Cells, Cultured; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006973:Hypertension / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D015398:Signal Transduction; D019284:Thapsigargin / Q000494:pharmacology; D016212:Transforming Growth Factor beta / Q000502:physiology*
chemical_list: D004791:Enzyme Inhibitors; D016212:Transforming Growth Factor beta; D000804:Angiotensin II; D019284:Thapsigargin; D002118:Calcium